<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Tissières P</dc:creator>
  <dc:creator>Dunn-Siegrist I</dc:creator>
  <dc:creator>Schäppi M</dc:creator>
  <dc:creator>Elson G</dc:creator>
  <dc:creator>Comte R</dc:creator>
  <dc:creator>Nobre V</dc:creator>
  <dc:creator>Pugin J</dc:creator>
  <dc:date>2008</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Myeloid differentiation factor-2 (MD-2) is a lipopolysaccharide (LPS)-binding protein usually coexpressed with and binding to Toll-like receptor 4 (TLR4), conferring LPS responsiveness of immune cells. MD-2 is also found as a soluble protein. Soluble MD-2 (sMD-2) levels are markedly elevated in plasma from patients with severe infections, and in other fluids from inflamed tissues. We show that sMD-2 is a type II acute-phase protein. Soluble MD-2 mRNA and protein levels are up-regulated in mouse liver after the induction of an acute-phase response. It is secreted by human hepatocytic cells and up-regulated by interleukin-6. Soluble MD-2 binds to Gram-negative but not Gram-positive bacteria, and sMD-2 secreted by hepatocytic cells is an essential cofactor for the activation of TLR4-expressing cells by Gram-negative bacteria. Soluble MD-2 opsonization of Gram-negative bacteria accelerates and enhances phagocytosis, principally by polymorphonuclear neutrophils. In summary, our results demonstrate that sMD-2 is a newly recognized type II acute-phase reactant, an opsonin for Gram-negative bacteria, and a cofactor essential for the activation of TLR4-expressing cells. This suggests that sMD-2 plays a key role in the host innate immune response to Gram-negative infections.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/182560</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2007-06-097782</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/18056837</dc:relation>
  <dc:source>Blood. - 2008</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Cell Line</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Gram-Negative Bacteria</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Hematopoietic Stem Cell Transplantation</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Immunosuppression</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Kidney</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Lymphocyte Activation</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Lymphocyte Antigen 96</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Lymphoma</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Mice</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Mice, Inbred BALB C</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">T-Lymphocytes, Regulatory</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Toll-Like Receptor 4</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Transplantation, Isogeneic</dc:subject>
  <dc:title xmlns:ns16="xml" ns16:lang="en">Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
